ArticleNeoplasia (New York, N.Y.)2006

Phosphorylated epidermal growth factor receptor on tumor-associated endothelial cells in human renal cell carcinoma is a primary target for therapy by tyrosine kinase inhibitors.

Cheryl H Baker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.